AHT 1170 MODULE A QUIZ AND ASSIGNMENTS QUESTIONS AND ANSWERS WITH COMPLETE SOLUTION

AHT 1170 FinalWITH COMPLETE
SOLUTION

Vaccine factors - ANS>>Age aa aa aa



Species
Travel habits aa



Previous vaccine history aa aa aa



Geographical location aa



Housing situation aa aa



Type of vaccine aa aa



Health status aa




Core vaccine - ANS>>Recommended for all animals of a certain species
aa aa aa aa aa aa aa aa aa aa




Non core vaccines - ANS>>Optional vaccines that are recommended based on need
aa aa aa aa aa aa aa aa aa aa aa



and risk
aa aa




Not recommended vaccines - ANS>>Not shown to be efficacious
aa aa aa aa aa aa aa aa




Canine core vaccines - ANS>>Canine distemper virus
aa aa aa aa aa aa



Canine parvovirus aa aa



Canine adenovirus aa aa



Rabies

Feline core vaccines - ANS>>Feline parvovirus
aa aa aa aa aa aa



Feline calcivirus aa



Feline herpesvirus aa aa



Rabies

Canine non core vaccines - ANS>>Bordetella, influenza
aa aa aa aa aa aa




Feline non core vaccines - ANS>>Feline leukaemia
aa aa aa aa aa aa aa



FIV

Pharmacology - ANS>>Study of the effect of drugs on the structure and metabolism
aa aa aa aa aa aa aa aa aa aa aa aa



of tissue
aa aa




Pharmokinetics - ANS>>The action of drugs in the body, including absorption,
aa aa aa aa aa aa aa aa aa aa



distribution, metabolism and excretion
aa aa aa aa

, Patent - ANS>>The legal right given by the government to a company that originated
aa aa aa aa aa aa aa aa aa aa aa aa aa



a new drug, exclusive rights to manufacturers for that product for a certain amount of
aa aa aa aa aa aa aa aa aa aa aa aa aa aa aa



time
aa




Toxicology - ANS>>The study of the adverse effects of chemicals on tissues or
aa aa aa aa aa aa aa aa aa aa aa aa



bodies
aa




Withdrawal period - ANS>>The amount of time that it takes for a drug to be safely
aa aa aa aa aa aa aa aa aa aa aa aa aa aa aa



eliminated from meat or milk after the use of that drug has been stopped
aa aa aa aa aa aa aa aa aa aa aa aa aa aa




Chemical name - ANS>>Describes its molecular structure
aa aa aa aa aa aa




Drug - ANS>>A substance used to diagnose, treat and prevent disease
aa aa aa aa aa aa aa aa aa aa




Generic name - ANS>>When a general drug is approved a federal agency is
aa aa aa aa aa aa aa aa aa aa aa aa



responsible for naming the drug, gives it a generic official name
aa aa aa aa aa aa aa aa aa aa aa




Trade name or brand name - ANS>>Unique exclusive name that a pharmaceutical
aa aa aa aa aa aa aa aa aa aa aa



company chooses to give to the drug that they are marketing
aa aa aa aa aa aa aa aa aa aa aa




Unapproved drug - ANS>>Does not have a DIN, never been approved by a Canadian
aa aa aa aa aa aa aa aa aa aa aa aa aa



regulatory authority
aa aa




Banned drug - ANS>>Drugs banned by health Canada from use in animals intended
aa aa aa aa aa aa aa aa aa aa aa aa



for use in human food
aa aa aa aa aa




Compound - ANS>>Mixing two or more ingredients together, at least one must be a
aa aa aa aa aa aa aa aa aa aa aa aa aa



drug
aa




Nutraceutical - ANS>>Nutrition and pharmaceutical, claims to provide a physiological
aa aa aa aa aa aa aa aa aa



benefit or protection against chronic disease, does not have DIN, and doesn't have
aa aa aa aa aa aa aa aa aa aa aa aa aa



rigorous scientific evidence of research and trial
aa aa aa aa aa aa aa




Absorption - ANS>>Process by which a drug crosses various barriers to reach the
aa aa aa aa aa aa aa aa aa aa aa aa



bloodstream
aa




Half life - ANS>>The time required for the amount of drug in the blood to be reduced
aa aa aa aa aa aa aa aa aa aa aa aa aa aa aa aa



by one half
aa aa aa




Summation (additive) - ANS>>Smaller amounts of each drug can be used, final
aa aa aa aa aa aa aa aa aa aa aa



response is equal to the sum of the individual responses to the drugs
aa aa aa aa aa aa aa aa aa aa aa aa aa




Synergism - ANS>>Final response to using two or more drugs together is greater
aa aa aa aa aa aa aa aa aa aa aa aa



than the sum of the individual responses to the drugs
aa aa aa aa aa aa aa aa aa aa




Antagonism - ANS>>Block another drug from combining with receptors
aa aa aa aa aa aa aa aa